Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Raw Materials (2019 - 2025)

Xtant Medical Holdings has reported Raw Materials over the past 7 years, most recently at $5.7 million for Q4 2025.

  • Quarterly Raw Materials fell 14.09% to $5.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Dec 2025, down 14.09% year-over-year, with the annual reading at $5.7 million for FY2025, 14.09% down from the prior year.
  • Raw Materials was $5.7 million for Q4 2025 at Xtant Medical Holdings, up from $5.6 million in the prior quarter.
  • Over five years, Raw Materials peaked at $7.3 million in Q4 2023 and troughed at $3.8 million in Q1 2021.
  • The 5-year median for Raw Materials is $5.7 million (2022), against an average of $5.8 million.
  • Year-over-year, Raw Materials soared 49.4% in 2021 and then dropped 23.22% in 2025.
  • A 5-year view of Raw Materials shows it stood at $5.6 million in 2021, then grew by 0.27% to $5.6 million in 2022, then rose by 29.16% to $7.3 million in 2023, then fell by 8.9% to $6.6 million in 2024, then dropped by 14.09% to $5.7 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Raw Materials are $5.7 million (Q4 2025), $5.6 million (Q3 2025), and $5.4 million (Q2 2025).